Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polygonin injection for traumatic shock
CTR20160804Phase 2Active
- Sponsor
- Shenzhen Neptunus Pharmaceutical
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of polydatin in Traumatic shock, sponsored by Shenzhen Neptunus Pharmaceutical. Started Nov 2016; status: active.
02
Drugs
polydatin
03
Conditions
Traumatic shock
Beyond the preview
Go deeper on CTR20160804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160804.